Serum 25-hydroxyvitamin D concentrations are associated with erythrocyte levels of n-3 PUFA but not risk of CVD

British Journal of Nutrition

Volumn 106, Issue 10, 2011, Pages 1529-1534

  Park, Yongsoon ^a   Kim, Minkyung ^a  

^a Hanyang University   (South Korea)

Author keywords

CVD; Erythrocyte fatty acid composition; Serum 25 hydroxyvitamin D

Indexed keywords

25 HYDROXYVITAMIN D; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; SATURATED FATTY ACID; STEARIC ACID;

ADULT; AGE; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHROCYTE LEVEL; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; SEASONAL VARIATION; SEX; SMOKING; VITAMIN BLOOD LEVEL;

ADULT; AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; ERYTHROCYTES; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; VITAMIN D;

EID: 80755176274     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511001930     Document Type: Article

References (31)

1. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357, 266-281.
2. Michos ED & Melamed ML (2008) Vitamin D and cardiovascular disease risk. Curr Opin Clin Metab Care 11, 7-12. (Pubitemid 350295219)
3. Zittermann A, Schleithoff SS & Koerfer R (2005) Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 94, 483-492. (Pubitemid 41555486)
4. Giovannucci E, Liu Y, Hollis BW, et al. (2008) 25-Hydroxyvitamin D and risk of myocardial infarction in men. A prospective study. Arch Intern Med 168, 1174-1180. (Pubitemid 351831400)
5. Kilkkinen A, Knekt P, Aro A, et al. (2009) Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol 170, 1032-1039.
6. Dobnig H, Pilz S, Scharnagl H, et al. (2008) Independent association of low serum 25-hydroxyvitmin D and 1,25-dihydroxyvitamin D levels with all cause and cardiovascular mortality. Arch Intern Med 168, 1340-1349. (Pubitemid 351930842)
7. Melamed ML, Michos ED, Post W, et al. (2008) 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168, 1629-1637.
8. Martins D, Wolf M, Pan D, et al. (2007) Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitmain D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167, 1159-1165. (Pubitemid 46919818)
9. Hsia J, Heiss G, Ren H, et al. (2007) Calcium/vitamin D supplementation and cardiovascular events. Circulation 115, 846-854. (Pubitemid 46294725)
10. Newhouser ML, Wassertheil-Smoller S, Thomson C, et al. (2009) Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts. Arch Intern Med 169, 294-304.
11. Harris WS & Von Schacky C (2004) The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med 39, 212-220. (Pubitemid 38797975)
12. Park Y, Lim J, Lee J, et al. (2009) Erythrocyte fatty acid profiles can predict acute non-fatal myocardial infarction. Br J Nutr 102, 1255-1361.
13. Park Y, Park S, Yi HJ, et al. (2009) Low level of n-3 polyunsaturated fatty acids in erythrocytes is a risk factor for both acute ischemic and hemorrhagic stroke in Koreans. Nutr Res 29, 825-830.
14. Burr ML, Fehily AM, Gilbert JF, et al. (1989) Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 334, 757-761. (Pubitemid 19234807)
15. Marchioli R, Barzi F, Bomba E, et al. (2002) Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105, 1897-1903. (Pubitemid 34437615)
16. Yokoyama M, Origasa H, Matsuzaki M, et al. (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomized open-label, blinded endpoint analysis. Lancet 369, 1090-1098. (Pubitemid 46483662)
17. Korean National Health and Nutrition Examination Office (2005) Report on the Korean National Health and Nutrition Examination Survey. Seoul, Korea: Korean National Health and Nutrition Examination Office.
18. Nogi A, Yang J, Limei L, et al. (2007) Plasma n-3 polyunsaturated fatty acid and cardiovascular disease risk factors in Japanese, Korean and Mongolian works. J Occup Health 49, 205-216. (Pubitemid 47036469)
19. Lym YL & Joh HK (2009) Serum 25-hydroxyvitamin D3 is related to fish intake and exercise in Korean adult men. Asia Pac J Clin Nutr 18, 372-376.
20. van der Meer IM, Boeke AJ, Lips P, et al. (2008) Fatty fish and supplements are the greatest modifiable contributors to the serum 25-hydroxyvitamin D concentration in a multiethnic population. Clin Endocrinol (Oxf) 68, 466-472. (Pubitemid 351257868)
21. Li YC, Kong J, Wei M, et al. (2002) 25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the rennin-angiotensin system. J Clin Invest 110, 229-238. (Pubitemid 34787360)
22. Carthy EP, YamashitaW, Hsu A, et al. (1988) 1,25-Dihydroxyvitamin D3 and rat vascular smooth muscle cell growth. Hypertension 13, 954-959.
23. Shioi A, Katagi M, Okuno Y, et al. (2002) Induction of bonetype alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. Circ Res 91, 9-16. (Pubitemid 34778936)
24. Rigby WF, Denome S & Fanger MW (1987) Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Invest 79, 1659-1664. (Pubitemid 17117271)
25. Wakasugi M, Noguchi T, Inoue M, et al. (1991) Vitamin D3 stimulates the production of prostacyclin by vascular smooth muscle cells. Prostaglandins 42, 127-136.
26. Zittermann A & Koerfer R (2008) Protective and toxic effects of vitamin D on vascular calcification: clinical implications. Mol Aspects Med 29, 423-432.
27. Wang TJ, Pencina MJ, Booth SL, et al. (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117, 503-511.
28. Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84, 18-28. (Pubitemid 44699167)
29. Kim MK, Kang IM, Oh WK, et al. (2010) The association of serum vitamin D level with presence of metabolic syndrome and hypertension in middle-aged Korean subjects. Clin Endocrinol (Oxf) 73, 330-338.
30. National Health, Medical Research Council (2006) Nutrient Reference Values for Australia and New Zealand. Australia: Department of Health and Ageing.
31. WelchAA, Shakya-Shrestha S&LentjesMA(2010)Dietary intake and status of n-3 polyunsaturated fatty acids in a population of fish-eating and non-fish-eating meat-eaters, vegetarians, and vegans and the precursor-product ratio of {alpha}-linolenic acid to long-chain n-3 polyunsaturated fatty acids: results from the EPIC-Norfolk cohort. Am J Clin Nutr 92, 1040-1051.